Delivery Order SPE2DB24D2011-SPE2DB24FBPLB

Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $2.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Isosorbide Dinitrate 40 mg tablets. The contract has a firm fixed price of $7,820.57 and a period of performance through December 16, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,291.05, is a Firm Fixed Price Delivery Order to supply 4,567,317,518 units of Isosorbide Dinitrate 40 mg tablets to the DLA. The contract has an ultimate completion date of February 20, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.92, is for the delivery of 4,568,171,219 units of Isosorbide Mononitrate 20 mg tablets in 100-count packages. The contract is a firm-fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of 4,565,682,131 units of Isosorbide Dinitrate 40 mg tablets. The award is valued at $12,234.05 and has a completion date of September 5, 2024. The contract is a firm-fixed price arrangement with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medical commodities,...
This federal contract award, valued at $47,793.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the...
This federal contract award, valued at $3,479.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,722,938 units of Isosorbide Dinitrate 40 mg tablets, a drug used for the treatment of cardiovascular conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,404.80 firm-fixed-price contract is for the delivery of the pharmaceutical product ISORDIL 40 MG TABLET 100S, with a completion date of August 29, 2022. The award was made without a set-aside designation. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,378.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including prescription medications, medical devices, and healthcare-related supplies. The contract has a ceiling value of $4,097.29 and a period of performance through April 11, 2025. The award is not set aside and is under a firm fixed-price pricing arrangement. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,466.40 and is a firm fixed-price, non-set-aside delivery order. It covers the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple therapeutic domains such as diabetes, neurology, pain...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBPLB
    Delivery Order

This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The award is for the supply of Isosorbide Dinitrate 30 mg tablets in 100 count bottles. The contract has a ceiling value of $2,060.07 and a performance period ending on April 18, 2024. This order is placed against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the U.S. Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 7/17/24, 9:33 AM